The growing demand for advanced plasma derived therapeutics, innovative rare disease therapeutics, and specialized immunology biologics is transforming the global healthcare landscape. Plasma-based medicines have become essential in treating complex immune disorders, hereditary conditions, and life-threatening diseases where conventional therapies may provide limited benefits. Among these...